Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
960.15
Change Change %
2.10 0.22%

Updated:19 Sep, 2018, 15:51 PM IST

BSE
985.10
Change Change %
26.05 2.72%

Updated:19 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
11-04-2016 Buy 1023.00 1140.00
N/A
Target Hit Long (1Y)
11-04-2017

Citi initiates Dr. Lal Pathlabs with buy

Company is a multi-year growth play. High return ratio will drive higher earnings multiples. See potentially higher dividends in the company. See a 50 per cent premium to average Asian hospitals.

Top